LOS ANGELES, CALIFORNIA — (BUSINESS WIRE) — September 02, 2011 — Catasys, Inc. (CATS) announced effective September 6, 2011 that its Board of Directors has declared a reverse stock split of its common stock at a 1 for 40 ratio. Catasys shareholders will receive one new share of Catasys common stock for every forty shares held. The split is part of the Company’s initiatives to improve its capital markets appeal to investors. The Company anticipates that the reverse stock split when combined with anticipated future contractual activity and other anticipated Company initiatives over the next quarter, will enable the Company to list on a National Stock Exchange.
The reverse split, which was approved by Catasys shareholders in March 2011, will reduce the number of shares of outstanding common stock to approximately 21 million. In lieu of fractional shares, shareholders will receive cash. Additional details and instructions for shareholder stock certificate exchanges will be mailed to shareholders of record as of the date of the split. Catasys’s transfer agent is the American Stock Transfer & Trust Company, LLC, who can be reached toll-free at 877-248-6417.
Through October 3, 2011, shares of Catasys will trade on the OTCBB under the symbol “CATSD” (with the extra letter “D” to indicate the reverse split). Thereafter, the shares of Catasys will resume trading under the symbol “CATS.”
Catasys, Inc. provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. For further information, please visit www.catasyshealth.com.
for statements of historical fact, the matters discussed in this press
release are forward looking and made pursuant to the Safe Harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements reflect numerous assumptions and
involve a variety of risks and uncertainties, many of which are beyond
the company's control that may cause actual results to differ materially
from stated expectations. These risk factors include, among others,
changes in regulations or issuance of new regulations or
interpretations, limited operating history and lack of outcomes and
statistically significant formal research studies, difficulty enrolling
members in our programs, the risk that treatment programs might not be
effective, difficulty in developing, exploiting and protecting
proprietary technologies, intense competition and substantial regulation
in the health care industry; and additional risks factors as discussed
in the reports filed by the company with the Securities and Exchange
Commission, which are available on its website at http://www.sec.gov